www.biomedcentral.com

Table 1
Demographic and clinical data of Tourette patients (n=21)
Subject	Age	Sex	OCD	ADHD	YGTSS global	YGTSS impairment	Current daily medication	Lifetime daily medication
1	42	F	No	No	46	30	None	Tiapride up to 600mg
2	18	M	Yes	No	33	10	Sulpiride 100mg	Sulpiride 100mg
3	36	M	No	No	48	20	None	None
4	40	M	No	No	49	30	Tiapride 100mg	Tiapride 300mg
5	19	M	N0	No	21	10	None	None
6	19	M	No	No	43	20	None	Pimozide 2mg
7	24	M	No	No	37	10	None	None
8	37	M	Yes	No	57	30	Pimozide 4mg Citalopram 20mg	Pimozide 6mg Citalopram 20mg
9	21	M	No	Yes	56	30	Tiapride 400mg Methylphenidate 60mg	Tiapride 800mg Methylphenidate 60mg
10	38	M	No	No	37	10	None	None
11	25	F	No	Yes	43	20	Pimozide 2mg Methylphenidate 40mg	Pimozide 2mg Methylphenidate 40mg
12	23	M	No	No	24	10	None	None
13	22	F	No	No	37	20	Trimipramine 50mg	Trimipramine 50mg
14	24	M	No	No	49	20	None	None
15	27	M	No	No	47	20	Trimipramine 100mg	Trimipramine 100mg
16	27	M	Yes	No	55	30	None	None
17	28	F	No	No	47	20	Pimozide 2mg	Pimozide 2mg
18	47	M	Yes	No	69	30	None	None
19	48	M	No	No	37	20	None	None
20	48	M	No	No	53	30	None	Tiapride 100mg
21	35	M	Yes	No	48	20	None	Tiapride up to 400mg

(OCD = comorbid obsessive compulsive disorder, ADHD = comorbid attention deficit hyperactivity disorder, YGTSS = Yale Global Tic Severity Scale).

Neuner et al. BMC Neurology 2012 12:120 doi:10.1186/1471-2377-12-120

Table 1